N
Neurent Medical
Health Tech & Medtech · Oranmore, Ireland · Founded 2015
Pioneering innovative treatments for chronic inflammatory sino-nasal diseases. MoreLess
Neurent Medical is pioneering innovative treatments for chronic inflammatory sino-nasal diseases by targeting and disrupting hyperactive autonomic nerves that drive the underlying inflammation. NEUROMARK is a gentle in-office treatment for chronic rhinitis, a common condition characterized by persistent symptoms of nasal congestion, nasal drainage, and numerous other symptoms that severely impact patient quality of life.
Company overview
Neurent Medical company information
The essential company record, classifications and operating signals in one place.
- Status
- Operational
- Founded
- 2015
- Headquarters
- Oranmore, Ireland
- Employees
- 80
- Open positions
- None listed
- Dealroom signal
- 93.5
Valuation & funding
Neurent Medical funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| GROWTH EQUITY VCOther financing | Feb 2026 | $69M | — | Enterprise Ireland · MVM Life Science Partners · Sofinnova Partners · Atlantic Bridge | ↗ |
| GROWTH EQUITY VCOther financing | Dec 2024 | $9M | — | Claret Capital Partners | ↗ |
| EARLY VCOther financing | Sep 2024 | $20M | $80M | Enterprise Ireland | ↗ |
| EARLY VCOther financing | Sep 2023 | $5.1M | $20M | Undisclosed | ↗ |
| SERIES BOther financing | Jan 2021 | $25M | $100M | Fountain Healthcare Partners · EQT Life Sciences · Atlantic Bridge | ↗ |
| GRANTOther financing | Jul 2020 | EIT Health | ↗ | ||
| SEEDOther financing | May 2018 | Western Development Commission · Enterprise Ireland · Atlantic Bridge · Fountain Healthcare Partners | ↗ | ||
| SPINOUTOther financing | Jan 2015 | University of Galway | — |
Financials
Revenue, earnings and profit over time
Reported history and available estimates. Estimated years are marked “E”; sparse fields are left blank rather than inferred.
| Year | Revenue | Growth | EBITDA | Margin |
|---|---|---|---|---|
| 2026 | $250K | 0% | −$7.3M | -2897.8% |
| 2025 | $250K | 0% | −$7.3M | -2897.8% |
| 2024 | $250K | 0% | −$7.3M | -2897.8% |
| 2023 | $250K | 0% | −$7.3M | -2897.8% |
| 2022 | $250K | — | −$7.3M | -2897.8% |
| 2021 | — | — | −$7.3M | — |
| 2020 | — | — | −$4.4M | — |
Growth signals
Neurent Medical website traffic
Latest recorded traffic for Neurent Medical is 5.2K monthly website visits, down 34.2% over the last three months. Neurent Medical's team grew 25% over the past year.
Comparisons
Neurent Medical compared with similar companies
Dealroom’s weighted taxonomy model identifies the closest operating peers. Company identity and context stay open; selected comparison metrics preview what is available in the platform.
Talent graph
Neurent Medical's talent
Source: Dealroom Talent Intelligence.
Investors
10 investors on Neurent Medical's cap table
Sourced from Dealroom's funding and investor records. Investor profile links are shown where available.
Global footprint
Where Neurent Medical has talent and traffic
team presence
In the news
Latest news about Neurent Medical
Recent press, funding announcements, and product moves mentioning Neurent Medical — open to read from the original sources.
Market sentiment
What the market is saying about Neurent Medical
An AI-synthesized read of the highest-engagement posts about Neurent Medical on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Neurent Medical’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.